SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001509190-15-000016
Filing Date
2015-05-08
Accepted
2015-05-08 16:27:17
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q petx-20150331x10q.htm 10-Q 1639567
2 EX-31.1 petx-20150331xex311.htm EX-31.1 20365
3 EX-31.2 petx-20150331xex312.htm EX-31.2 20659
4 EX-32.1 petx-20150331xex321.htm EX-32.1 7285
5 EX-32.2 petx-20150331xex322.htm EX-32.2 7992
  Complete submission text file 0001509190-15-000016.txt   11434703

Data Files

Seq Description Document Type Size
6 EX-101.INS petx-20150331.xml EX-101.INS 2110389
7 EX-101.SCH petx-20150331.xsd EX-101.SCH 47413
8 EX-101.CAL petx-20150331_cal.xml EX-101.CAL 74780
9 EX-101.DEF petx-20150331_def.xml EX-101.DEF 211516
10 EX-101.LAB petx-20150331_lab.xml EX-101.LAB 392213
11 EX-101.PRE petx-20150331_pre.xml EX-101.PRE 377571
Mailing Address 1901 OLATHE BOULEVARD KANSAS CITY KS 66103
Business Address 1901 OLATHE BOULEVARD KANSAS CITY KS 66103 913.951.2130
ARATANA THERAPEUTICS, INC. (Filer) CIK: 0001509190 (see all company filings)

IRS No.: 383826477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35952 | Film No.: 15847161
SIC: 2834 Pharmaceutical Preparations